fashion -WSS

fashion

author：explore 2025-10-01 17:19:29 - browse：66528

Sammy Kimball for STAT

What can Homer teach us about biotech? Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. We also discuss the latest news in the life sciences, including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant.

For more on what we cover, here’s the news on BridgeBio; here’s more on the Stanford president; here’s the latest on the Pfizer plant; here’s the story on Eli Lilly’s Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Psychedelics group wrestles with new pharma identity

focus

WSS

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Activists slam private health insurers over coverage restrictions

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Venture capitalist Bob Kocher on the state of digital health

hotspot

fashion

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medical leaders decry Supreme Court decision on affirmative action

ChatGPT in medicine: STAT answers readers' burning questions

Criminal prosecution for violating HIPAA: an emerging threat

Drug repurposing or repositioning? The language matters

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

State Dept. review finds Biden bears some blame for Afghanistan failures

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Activists slam private health insurers over coverage restrictions

Walensky prepares to leave CDC — and Congress — behind

hotspot

When prostate cancer spreads, where it goes matters

BioMarin wins approval for gene therapy to treat hemophilia A

Novavax promises a turnaround & Lilly roils the obesity market

Cytokinetics CEO stresses company can launch heart drug on its own

At least 13 dead in Texas as scorching temps continue

New air purifier tech could be key to improving indoor air quality

leisure time

hotspot

focus

focus